β-Adrenergic sweat secretion as a diagnostic test for cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 8, 2012, Pages 732-739

  Quinton, Paul ^a,c   Molyneux, Laura ^a   Ip, Wan ^d,f   Dupuis, Annie ^e   Avolio, Julie ^d,f   Tullis, Elizabeth ^f,g   Conrad, Douglas ^b   Shamsuddin, A K ^a   Durie, Peter ^d,f   Gonska, Tanja ^d,f  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Research Institute   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Biomarker; Cystic fibrosis; Diagnostic test; Sweat test

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BETA ADRENERGIC STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HETEROZYGOTE; HUMAN; INJECTION SITE BURNING; IONTOPHORESIS; MALE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PRURITUS; QUANTITATIVE PILOCARPINE IONTOPHORESIS; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; SKIN REDNESS; SWEATING;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HETEROZYGOTE DETECTION; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWEAT; WATER LOSS, INSENSIBLE;

EID: 84867608087     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201205-0922OC     Document Type: Article

References (26)

1. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-549.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073. [Published erratum appears in Science 1989;29:245]. (Pubitemid 19231814)
3. Quinton PM. Cystic fibrosis: lessons from the sweat gland. Physiology (Bethesda) 2007;22:212-225.
4. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, et al.; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-S14. (Pubitemid 351970581)
5. Shwachman H, Mahmoodian A. Pilocarpine iontophoresis sweat testing results of seven years' experience. Bibl Paediatr 1967;86:158-182.
6. Knowles MR, Durie PR. What is cystic fibrosis? N Engl J Med 2002;347:439-442. (Pubitemid 34851838)
7. Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E, Martin S, Corey M, Tsui LC, Durie P. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Respir Crit Care Med 2006;174:787-794. (Pubitemid 44511660)
8. Ooi CY, Dorfman R, Cipolli M, Gonska T, Castellani C, Keenan K, Freedman SD, Zielenski J, Berthiaume Y, Corey M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011;140:153-161.
9. Gonska T, Choi P, Stephenson A, Ellis L, Martin S, Solomon M, Dupuis A, Dorfman R, Zielenski J, Ooi CY, et al. Role of cystic fibrosis transmembrane regulator (CFTR) in patients with chronic sinopulmonary disease. Chest 2012; Epub ahead of print.
10. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004;126:1215-1224. (Pubitemid 39391253)
11. Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis 2010;33:S255-S261.
12. Sato K, Sato F. Defective b-adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. J Clin Invest 1984;73:1763-1771. (Pubitemid 14084494)
13. Behm JK, Hagiwara G, Lewiston NJ, Quinton PM, Wine JJ. Hyposecretion of B-adrenergically induced sweating in CF heterozygotes. Pediatr Res 1987;22:271-276. (Pubitemid 17162787)
14. Nuutinen J, Alanen E, Autio P, Lahtinen MR, Harvima I, Lahtinen T. A closed unventilated chamber for the measurement of transepidermal water loss. Skin Res Technol 2003;9:85-89. (Pubitemid 36603649)
15. Elkeeb R, Hui X, Chan H, Tian L, Maibach HI. Correlation of transepidermal water loss with skin barrier properties in vitro: comparison of three evaporimeters. Skin Res Technol 2010;16:9-15.
16. Schmidt R, Weidner C, Schmelz M. Time course of acetylcholine-induced activation of sympathetic efferents matches axon reflex sweating in humans. J Peripher Nerv Syst 2011;16:30-36.
17. Ip W, Molyneux L, Dupuis A, Avolio J, Tullis E, Conrad D, Durie P, Quinton P, Gonska T. Beta-adrenergic sweat secretion rate as accurate biomarker for CFTR function. J Cyst Fibros 2012;11:S32.
18. Bombieri C, Claustres M, de Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M,Wilschanski M, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 2011;10:S86-S102.
19. Hammond KB, Turcios NL, Gibson LE. Clinical evaluation of the Macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatr 1994;124:255-260. (Pubitemid 24057794)
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310. (Pubitemid 16134762)
21. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG; Standards for Reporting of Diagnostic Accuracy Group. Standards for reporting of diagnostic accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003;49:1-6. (Pubitemid 36078546)
22. Funk MJ, LeGrys VA. Testing diagnostic tests: why size matters. J Pediatr 2005;146:159-162. (Pubitemid 40202799)
23. Highsmith WE, Burch LH, Zhou Z, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittel L, Friedman KJ, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994;331:974-980. (Pubitemid 24304583)
24. Burgel PR, Fajac I, Hubert D, Grenet D, Stremler N, Roussey M, Siret D, Languepin J, Mely L, Fanton A, et al. Non-classic cystic fibrosis associated with D1152H CFTR mutation. Clin Genet 2010;77:355-364.
25. Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010;363:1991-2003.
26. Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, Nissim-Rafinia M, Blau H, Rivlin J, Aviram M, et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008;372:719-727.